Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Xiaofan Pu

Matched on ORCID iD 0009-0001-3064-0071; OpenAlex author ID A5002149879. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Filgotinib inhibits METTL3-mediated m6A of EIF3A by targeting ERG-TBP to suppress PDAC progression JAK-STAT3-independently. Co-author DOI 10.1038/s41698-026-01396-z↗
  2. Immune-related gene SOX10 affects ferroptosis in pancreatic cancer and facilitates tumor progression by targeting CMTM7-mediated Wnt/β-catenin signaling pathwa… Co-author DOI 10.1186/s40001-024-02177-9↗
  3. Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods. Co-author DOI 10.1016/j.tranon.2023.101847↗
  4. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex. First author DOI 10.1016/j.bbagrm.2023.194941↗
  5. Identification of exosomal miR-484 role in reprogramming mitochondrial metabolism in pancreatic cancer through Wnt/MAPK axis control. First author DOI 10.1016/j.phrs.2023.106980↗
  6. Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress. Co-author DOI 10.1096/fj.201902186r↗
  7. Elevated expression of exosomal microRNA-21 as a potential biomarker for the early diagnosis of pancreatic cancer using a tethered cationic lipoplex nanopartic… Co-author DOI 10.3892/ol.2020.11302↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengnan Jia · 3 shared papers, 2023–2026 · strength 0.70
  2. Chaolei Zhang · 3 shared papers, 2023–2026 · strength 0.70
  3. Liping Cao · 4 shared papers, 2020–2024 · strength 0.66
  4. Tianyu Lin · 2 shared papers, 2023–2025 · strength 0.44
  5. Guoping Ding · 3 shared papers, 2020–2023 · strength 0.44
  6. Tao Shen · 2 shared papers, 2020–2024 · strength 0.34
  7. Kexiong Qiao · 1 shared paper, 2026 · strength 0.30
  8. Liangjing Zhou · 1 shared paper, 2026 · strength 0.30
  9. Guixing Jiang · 1 shared paper, 2025 · strength 0.26
  10. Tianshu Pang · 1 shared paper, 2024 · strength 0.22
  11. Dongnan Ping · 1 shared paper, 2023 · strength 0.18
  12. Yuelong Liang · 1 shared paper, 2023 · strength 0.18
  13. Yiyin Zhang · 1 shared paper, 2023 · strength 0.18
  14. Shengnan Jia · 1 shared paper, 2020 · strength 0.13
  15. Xiaodong Xu · 1 shared paper, 2020 · strength 0.12
  16. Zhengrong Wu · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.